Speth, C.; Bellotti, R.; Schäfer, G.; Rambach, G.; Texler, B.; Thurner, G.C.; Öfner, D.; Lass-Flörl, C.; Maglione, M.
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Curr. Oncol. 2022, 29, 9833-9854.
https://doi.org/10.3390/curroncol29120773
AMA Style
Speth C, Bellotti R, Schäfer G, Rambach G, Texler B, Thurner GC, Öfner D, Lass-Flörl C, Maglione M.
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current Oncology. 2022; 29(12):9833-9854.
https://doi.org/10.3390/curroncol29120773
Chicago/Turabian Style
Speth, Cornelia, Ruben Bellotti, Georg Schäfer, Günter Rambach, Bernhard Texler, Gudrun C. Thurner, Dietmar Öfner, Cornelia Lass-Flörl, and Manuel Maglione.
2022. "Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment" Current Oncology 29, no. 12: 9833-9854.
https://doi.org/10.3390/curroncol29120773
APA Style
Speth, C., Bellotti, R., Schäfer, G., Rambach, G., Texler, B., Thurner, G. C., Öfner, D., Lass-Flörl, C., & Maglione, M.
(2022). Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Current Oncology, 29(12), 9833-9854.
https://doi.org/10.3390/curroncol29120773